Navigation Links
One Year After TomoTherapy Acquisition, Accuray on Track to Meet or Exceed Integration Success Metrics And Expecting Near-term Return to Profitability
Date:6/21/2012

SUNNYVALE, Calif., June 21, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the company's successes since its acquisition of TomoTherapy Incorporated one year ago and its vision for growth and profitability in the future, as part of a presentation by the company's chief financial officer Derek Bertocci at the Wells Fargo Healthcare Conference in Boston.

As part of Accuray's transformative acquisition of TomoTherapy Incorporated on June 10, 2011, the company set forth success metrics. Through the first three quarters of FY2012, Accuray has consistently met or exceeded these goals.

In addition to reiterating the company's plans to return to profitability by the end of fiscal year 2013, which ends June 30, 2013, Accuray provided additional milestones for its fiscal year 2013. These included enhanced revenue growth, beyond the maintained or modestly increased revenue the company committed to for fiscal 2012. Specific guidance for fiscal year 2013 will be announced during Accuray's earnings call for the results for 4th quarter of fiscal 2012, but the company intends to focus on maximizing product sales through continued product innovation and market penetration. 

Accuray also anticipates further service gross margin improvements reaching 20-22 percent for the full fiscal year 2013, which is higher than originally announced. This continues the significant achievement of three consecutive quarters of strong service gross margin improvements during fiscal 2012, climbing to 16.1 percent in Q3 of fiscal 2012, surpassing the company's original goal of 10 percent by the end of fiscal 2012. Service gross margin improvements stemmed primarily from improvement in the reliability of TomoTherapy® Systems, which has enhanced customer confidence and helped driv
'/>"/>

SOURCE Accuray Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
3. Parent Project Muscular Dystrophy Endorses Senate Version of Prescription Drug User Fee Act After Patient Voice Strengthened
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Accuray Announces Results for Third Quarter Fiscal 2012
6. Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
7. Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement
8. Accuray Incorporated to Speak at Jefferies Global Healthcare Conference
9. Accuray Incorporated to Speak at Wells Fargo Healthcare Conference
10. Accuray Rolls Out Comprehensive Customer Service Program in Japan
11. Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software at ISBER 2012 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)...   Aratana Therapeutics, Inc . (NASDAQ: ... licensing, development and commercialization of innovative biopharmaceutical products for ... the Barclays Global Healthcare Conference to be ... Hotel in Miami , FL.  ... and Chief Executive Officer of Aratana Therapeutics, will provide ...
(Date:3/4/2015)... 2015  Results of the recent study, Results ... for Intra-Operative Positive Margin Detection , were presented as ... nd Annual Miami Breast Cancer Conference last week. ... Papa , MD, FACS, Professor of Surgery at the ... an analysis of MarginProbe,s efficiency and accuracy when used ...
(Date:3/4/2015)... 2015 Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in ... cancer, today announced that James A. Joyce , ... overview at the 27th Annual ROTH Conference on March ... Laguna Niguel, California . To learn more about ... A live webcast of the presentation will be ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2Aethlon Medical to Present at the 27th Annual ROTH Conference 2
... Plan for Biomarker Study -, MONTVALE, N.J., ... ) today announced that it plans to,conduct a ... nicotinic alpha-7,partial agonist, on two biomarkers of schizophrenia, ... schizophrenia. The biomarker study,and additional formulation and manufacturing ...
... Developed Test in the U.S. for Detecting the ... Mosquito-Borne Infectious Disease, ... diagnostics company of Quest Diagnostics (NYSE: DGX ),today announced ... mosquito-borne chikungunya virus. Commercial availability of,the molecular polymerase chain reaction ...
Cached Medicine Technology:Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia 2Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia 3Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia 4Focus Diagnostics Launches Laboratory Test for Chikungunya Virus 2Focus Diagnostics Launches Laboratory Test for Chikungunya Virus 3Focus Diagnostics Launches Laboratory Test for Chikungunya Virus 4
(Date:3/4/2015)... March 05, 2015 The emergence ... landscape over the past decade. The pharmaceutical world ... drug delivery in the form of liposomes and ... drugs with more safety and efficiency. In ... perhaps rely greatly upon the enhanced permeability and ...
(Date:3/4/2015)... Las Vegas, NV (PRWEB) March 04, 2015 ... good as the fight that is the main event. For ... announced and that fight will be for the UFC Featherweight ... against the brash, often out-spoken native of Ireland, Conor “Notorious” ... the MGM Grand Garden Arena in Las Vegas, NV. , ...
(Date:3/4/2015)... Florida (PRWEB) March 04, 2015 Ultraman ... a 6.2 mile swim, 261.4 mile bike, and 52.4 ... a total time of 24:45:45. , "This race was ... to my wonderful team and sponsors for supporting me ... Ultraman Florida 2015 had a total of 40 select ...
(Date:3/4/2015)... Dr. Christopher Asandra, M.D., Founder and Chief Medical ... the FDA’s recent decision to issue a warning ... FDA’s conclusions are not supported by science, and that ... deficiency. , “The FDA appears to have developed a ... Dr. Asandra. “There is not nearly enough evidence to ...
(Date:3/4/2015)... TROY Healthcare Solutions will be introducing TROY Secure ... of security for prescriptions, in Houston, Texas on Wednesday, ... located at 6633 Travis Street from 7 AM to ... Healthcare Solutions will host a continental breakfast. Starting at ... each hour to introduce attendees to TROY Secure Print ...
Breaking Medicine News(10 mins):Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 3Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3
... National Football League (NFL) will give a $1 million ... Traumatic Encephalopathy (CSTE) at Boston University School of Medicine ... funds will be used to continue the Center,s ground-breaking ... in athletes, in particular football players. CSTE researchers have ...
... Minn. -- The growing number of Americans with cardiovascular ... of chest pain. In a study published in the ... reported that patients dismissed from the hospital with noncardiac ... highlight a need for more aggressive cardiovascular risk factor ...
... for inflammation , TUESDAY, April 20 (HealthDay News) -- ... have something to do with components of virgin olive ... study reports. , "These findings strengthen the relationship between ... most basic level of healthy effects derived from virgin ...
... ... , ... 20, 2010 -- As the debate around legalization intensifies from coast to coast, CNBC.com ... of business. "Marijuana & Money" thoroughly examines the current marketplace as well as ...
... ... $2500 so far in a weight loss challenge, benefiting City CURE’s Whiz Kids program. Dr. ... is to raise $3000. City CURE is a non-profit organization in Cincinnati whose goal is ... ...
... "I was ... her pancreatic cancer. But the Chicago woman refused to give up in her fight ... Hepatobiliary Diseases at Northwest Community Hospital in Arlington Heights, where the expertise of Dr. Malcolm ... ...
Cached Medicine News:Health News:NFL gives $1 million unrestricted gift to Boston University to study impact of brain injuries 2Health News:NFL gives $1 million unrestricted gift to Boston University to study impact of brain injuries 3Health News:Outcomes of patients dismissed from the hospital with non-cardiac chest pain 2Health News:CNBC.com Presents "Marijuana & Money" 2Health News:CNBC.com Presents "Marijuana & Money" 3Health News:CNBC.com Presents "Marijuana & Money" 4Health News:Dr. Sachin Patel Partners with City CURE to Raise $3000 in a Pound-4-Pound Challenge Benefiting Whiz Kids 2Health News:Given No Chance to Survive with Pancreatic Cancer, Chicago Woman Finds New Life at Northwest Community Hospital 2Health News:Given No Chance to Survive with Pancreatic Cancer, Chicago Woman Finds New Life at Northwest Community Hospital 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: